Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis
NCT02369432 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2017-10-13
Summary
This proof of concept study aims to assess in patients suffering from atopic dermatitis if polymeric microparticles reach the pilosebaceous follicles of inflamed skin.
Conditions
Interventions
- DRUG
-
Biodegradable and biocompatible polymeric microparticles containing a fluorochrome applied to the skin followed by a skin biopsy
Sponsors & Collaborators
-
University of Franche-Comté
collaborator OTHER -
Centre Hospitalier Universitaire de Besancon
lead OTHER
Principal Investigators
-
Philippe HUMBERT · Centre Hospitalier Universitaire de Besancon
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-02-20
- Primary Completion
- 2017-10-03
- Completion
- 2017-10-03
Countries
- France
Study Locations
More Related Trials
-
Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis
NCT04413942 ·Status: UNKNOWN ·Phase: PHASE2
-
Topical ENS-002 for Atopic Dermatitis in Adults
NCT06469385 ·Status: TERMINATED ·Phase: PHASE1
-
Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum
NCT04274348 ·Status: COMPLETED ·Phase: NA
-
Targeted Microbiome Transplant in Atopic Dermatitis
NCT03151148 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From AD
NCT05639738 ·Status: TERMINATED ·Phase: NA
-
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
NCT07105488 ·Status: RECRUITING ·Phase: PHASE2
-
French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
NCT06837454 ·Status: RECRUITING
-
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults
NCT01232985 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
NCT06756438 ·Status: RECRUITING ·Phase: NA
-
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
NCT03389893 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
NCT03738423 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
NCT02087943 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
NCT03720470 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
NCT01756898 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
NCT02277743 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis
NCT03817190 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
NCT06397911 ·Status: RECRUITING ·Phase: PHASE2
-
CT 327 in the Treatment of Atopic Dermatitis
NCT00996008 ·Status: TERMINATED ·Phase: PHASE2
-
Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis
NCT02780167 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating APG777 in Atopic Dermatitis
NCT06395948 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).
NCT05935085 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)
NCT02395133 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis
NCT04668066 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
NCT02002208 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis
NCT01548404 ·Status: COMPLETED ·Phase: PHASE2